Active/Completed Active GrantsCompleted Grants PI Name Sort descending PI Organization Title Grant Number Program Official Gill, Brian John Andrew Columbia University Health Sciences United States The Impact of Local and Reversible Change to GABAergic Inhibitory Signaling on Tumor-Induced Cortical Dysfunction in Glioma 1R01NS140658-01A1 Brandy Heckman-Stoddard, Ph.D., M.P.H. Gill, Brian John Andrew Columbia University Health Sciences United States The Impact of Local and Reversible Change to GABAergic Inhibitory Signaling on Tumor-Induced Cortical Dysfunction in Glioma 1R01NS140658-01A1 Brandy Heckman-Stoddard, Ph.D., M.P.H. Gonzalez, Brian D H. Lee Moffitt Cancer Ctr & Res Inst United States Impact of Targeted Therapy on Cancer-Related Cognitive Impairment 5R01CA287666-02 Brandy Heckman-Stoddard, Ph.D., M.P.H. Gonzalez, Brian D H. Lee Moffitt Cancer Ctr & Res Inst United States Impact of Targeted Therapy on Cancer-Related Cognitive Impairment 5R01CA287666-02 Brandy Heckman-Stoddard, Ph.D., M.P.H. Goode, Diana J University Of New England United States Novel expression of MHC class II on DRG neurons and its role in promoting antinociceptive CD4+ T cells in females during chemotherapy-induced peripheral neuropathy 5R01CA267554-04 Rachel Altshuler, Ph.D. Goode, Diana J University Of New England United States Novel expression of MHC class II on DRG neurons and its role in promoting antinociceptive CD4+ T cells in females during chemotherapy-induced peripheral neuropathy 5R01CA267554-04 Rachel Altshuler, Ph.D. Greene, Nicholas Perry University Of Arkansas At Fayetteville United States DEVELOPMENT OF TARGETED APPROACHES IN PREVENTION OF CANCER-CACHEXIA 5R01AR075794-05 Brandy Heckman-Stoddard, Ph.D., M.P.H. Greene, Nicholas Perry University Of Arkansas At Fayetteville United States DEVELOPMENT OF TARGETED APPROACHES IN PREVENTION OF CANCER-CACHEXIA 5R01AR075794-05 Brandy Heckman-Stoddard, Ph.D., M.P.H. Groninger, J. Hunter Medstar Health Research Institute United States Cognitive behavioral theory-assisted virtual reality for chronic cancer pain (VR-CAN): device prototype development and feasibility testing 1R21CA299799-01 Brennan Streck, Ph.D., RN, M.P.H. Groninger, J. Hunter Medstar Health Research Institute United States Cognitive behavioral theory-assisted virtual reality for chronic cancer pain (VR-CAN): device prototype development and feasibility testing 1R21CA299799-01 Brennan Streck, Ph.D., RN, M.P.H. Gross, Howard M Dayton Clinical Oncology Program United States Dayton Clinical Oncology Program 3UG1CA189957-11S1 Vanessa A. White, M.P.H. Gross, Howard M Dayton Clinical Oncology Program United States Dayton Clinical Oncology Program 3UG1CA189957-11S1 Vanessa A. White, M.P.H. Hall, Daniel Lee Massachusetts General Hospital United States Innovating CBT-I for Cancer Survivors: An Optimization Trial 5R21CA279248-02 Hall, Daniel Lee Massachusetts General Hospital United States Innovating CBT-I for Cancer Survivors: An Optimization Trial 5R21CA279248-02 Halmos, Balazs Montefiore Medical Center (Bronx, Ny) United States Montefiore Academic Communicty NCORP Program 3UG1CA189859-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H. Pagination « First First page ‹ Previous Previous page … 7 8 9 10 … Next › Next page Last » Last page